Disease-Free Survival of Patients with Muscle Invasive Bladder Cancer Treated by Radical Cystectomy vs. Bladder-Sparing Therapy at a Nationwide Level

被引：0

作者：

Bruck, K. ^{[1
]}

Meijer, R. P. ^{[2
]}

Boormans, J. L. ^{[3
]}

Kiemeney, L. A.

Witjes, F. ^{[4
]}

van der Heijden, M. S. ^{[5
]}

Franckena, M. ^{[3
]}

Leliveld, A. M. ^{[6
]}

Aben, K. K. ^{[7
]}

Hulshof, M.

Uyl, C. A. ^{[8
,9
]}

机构：

[1] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[2] Univ Med Ctr Utrecht, Utrecht, Netherlands

[3] Erasmus MC, Rotterdam, Netherlands

[4] Radboud UMC, Nijmegen, Netherlands

[5] Netherlands Canc Inst, Amsterdam, Netherlands

[6] Univ Med Ctr Groningen, Groningen, Netherlands

[7] Netherlands Comprehens Canc Org, Utrecht, Netherlands

[8] Univ Amsterdam, Med Ctr, Noord Holl, Netherlands

[9] Inst Med Technol Assessment, Rotterdam, Netherlands

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2455

引用

页码：E204 / E204

页数：1

共 50 条

[41] Chemoradiation therapy for patients with muscle invasive bladder cancer who are not candidates for radical cystectomy
Matsushima, M
Sawamura, Y
Tajima, M
Shirai, M
Itatani, H
AKTUELLE UROLOGIE, 2000, 31 : 22 - 24
[42] Will chemoradiation-based bladder-sparing therapy become a standard of care for muscle-invasive bladder cancer?
Koga, Fumitaka
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (03) : 981 - 982
[43] Correlation of disease-free survival at 2 to 3 years and 5-year overall survival in patients with muscle-invasive bladder cancer undergoing radical cystectomy.
Sonpavde, G.
Khan, M. M.
Lerner, S. P.
Svatek, R. S.
Skinner, E. C.
Karakiewicz, P. I.
Kassouf, W.
Dinney, C. P.
Fradet, Y.
Shariat, S. F.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[44] Trimodal therapy vs. radical cystectomy for muscle-invasive bladder cancer: A Canadian cost-effectiveness analysis
Kool, Ronald
Yanev, Ivan
Hijal, Tarek
Vanhuyse, Marie
Cury, Fabio L.
Souhami, Luis
Kassouf, Wassim
Dragomir, Alice
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2022, 16 (06): : 189 - 198
[45] Re: Propensity Score Analysis of Radical Cystectomy Versus Bladder-sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic
El-Achkar, Adnan
Kassouf, Wassim
EUROPEAN UROLOGY, 2018, 73 (05) : 810 - 811
[46] BLADDER PRESERVATION MULTIMODALITY THERAPY AS AN ALTERNATIVE TO RADICAL CYSTECTOMY FOR TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
Maarouf, A. M.
Khalil, S.
Salem, E.
Eladl, M.
Nawar, N.
Zaiton, F.
EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 37 - 37
[47] BLADDER PRESERVATION MULTIMODALITY THERAPY AS AN ALTERNATIVE TO RADICAL CYSTECTOMY FOR TREATMENT OF MUSCLE INVASIVE BLADDER CANCER
Choudhury, Ananya
Cowan, Richard
BJU INTERNATIONAL, 2011, 108 (09) : E313 - E313
[48] Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches
Koga, Fumitaka
Fujii, Yasuhisa
Masuda, Hitoshi
Numao, Noboru
Yokoyama, Minato
Ishioka, Jun-ichiro
Saito, Kazutaka
Kawakami, Satoru
Kihara, Kazunori
BJU INTERNATIONAL, 2012, 110 (6B) : E203 - E208
[49] Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer
Maarouf, Aref M.
Khalil, Salem
Salem, Emad A.
ElAdl, Mahmoud
Nawar, Nashwa
Zaiton, Fatma
BJU INTERNATIONAL, 2011, 107 (10) : 1605 - 1610
[50] PATHOLOGY-BASED RISK STRATIFICATION OF MUSCLE-INVASIVE BLADDER CANCER PATIENTS UNDERGOING CYSTECTOMY FOR PERSISTENT DISEASE AFTER INDUCTION CHEMORADIATION IN BLADDER-SPARING PROTOCOLS
Koga, Fumitaka
Yokoyama, Minato
Ishioka, Junichiro
Numao, Noboru
Saito, Kazutaka
Masuda, Hitoshi
Fujii, Yasuhisa
Kawakami, Satoru
Kihara, Kazunori
JOURNAL OF UROLOGY, 2011, 185 (04): : E568 - E569

← 1 2 3 4 5 →